New therapeutic use of heterocyclylpiperazines as 5-HT.sub.3 agonists and new compounds
US5447931A · kind A · utility
9Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 1994 |
| Grant date | Sep 5, 1995 |
| Priority date | — |
| Expiry date | Nov 17, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New therapeutic use of some heterocyclylpiperazines of formula (I) ##STR1## wherein R represents hydrogen or (C.sub.1 -C.sub.4)alkyl, R.sub.1 represents hydrogen or a methyl group, R.sub.2 represents hydrogen or a halogen atom; X et Y represent each --CH.dbd., or one is --CH.dbd. and the other is --N.dbd., as well as their pharmaceutically acceptable salts for the preparation of a medicament for the treatment or prophylaxis of the pathological conditions which can be improved by 5-HT.sub.3 mediated selective agonism and new compounds deriving from this chemical class.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.